SILVERARC CAPITAL MANAGEMENT, LLC - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 38 filers reported holding ELOXX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$187,000
-33.5%
1,098,469
+5.5%
0.06%
-27.6%
Q2 2022$281,000
-74.3%
1,041,499
-46.6%
0.09%
-80.8%
Q1 2022$1,092,000
-19.9%
1,950,949
+1.1%
0.45%
-18.1%
Q4 2021$1,363,000
-33.6%
1,930,092
+53.2%
0.55%
-52.5%
Q3 2021$2,054,000
-45.3%
1,259,840
-33.3%
1.16%
-30.7%
Q2 2021$3,756,0001,887,5391.68%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,950,949$1,092,0000.45%
AMERICAN FINANCIAL GROUP INC 1,480,000$829,0000.25%
Vanguard Capital Wealth Advisors 158,900$86,0000.06%
Atom Investors LP 113,151$63,0000.03%
Nantahala Capital Management 774,767$434,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,173,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$659,0000.01%
Altshuler Shaham Ltd 1,088,848$609,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 309,400$173,0000.00%
Clal Insurance Enterprises Holdings Ltd 585,000$328,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders